|
WO2021077113A1
|
|
Methods of treatment of bladder cancer by using modified bacillus calmette-guérin
|
|
WO2020102786A1
|
|
Methods for evaluation of duration of mycobacterial infection
|
|
US2020140573A1
|
|
Nucleic acid compositions, methods and kits for rapid pairing of affinity agents
|
|
US2020009227A1
|
|
Compositions and methods of controlling expression of thermogenin (ucp-1) in skeletal muscles
|
|
WO2019212603A2
|
|
Igm compositions and methods of mucosal delivery of these compositions
|
|
US2020113891A1
|
|
Novel amodiaquine analogs and methods of uses thereof
|
|
WO2018085834A1
|
|
Novel recombinant hiv compositions and uses thereof in animal models
|
|
US2019298820A1
|
|
Novel recombinant hiv epitopes and uses thereof
|
|
US2018177858A1
|
|
Involucrin-driven retroviral expression cassettes encoding human immunodeficiency virus envelope glycoproteins
|
|
US2018161333A1
|
|
Inhibitors of macropinocytosis in prevention and treatment of disease
|
